To the best of our knowledge, this is the first study investigating the effect of VD3 supplementation in PCOS rats on plasma levels of two adipokines—RARRES2 and ADIPOQ—as well as the transcript and protein expression of these adipokines and their receptors in the uterus. Here, ADIPOQ is linked to polycystic ovary syndrome.